Today: 21 May 2026
CoreWeave stock slips as lawsuit notices and insider-sale filing hit a hot trade
10 February 2026
1 min read

CoreWeave stock slips as lawsuit notices and insider-sale filing hit a hot trade

New York, Feb 10, 2026, 11:32 EST — Regular session

  • CoreWeave shares slipped roughly 2% in late morning trading, giving back some of Monday’s earlier gains.
  • Traders moved to secure profits after a securities class-action notice and an insider Form 144 filing started making the rounds.
  • Attention now turns to CoreWeave’s Feb. 26 results, with investors looking for any word on capacity build-out and funding requirements.

CoreWeave shares slipped roughly 2% to $94.84 on Tuesday, lagging behind a flat tech sector, as traders digested new legal developments and eyed a filing related to possible stock sales.

The stock’s drop is grabbing attention, largely because it’s become a go-to barometer for appetite in “AI infrastructure” plays. Then there’s the looming CoreWeave update, which complicates any bets here. Right now, the main argument centers on execution: just how fast can management ramp up power and data-center space without putting too much stress on the balance sheet? CoreWeave

On Monday evening, an SEC Form 144 revealed that a Brannin McBee-affiliated entity intended to unload a modest stake. The filing also detailed previous trades executed through preset Rule 10b5-1 plans, which insiders use to schedule stock sales.

Law firms on Monday and Tuesday rolled out notices related to a proposed securities class action against CoreWeave, telling investors they have until March 13 to seek lead-plaintiff status. The firms cited previous disclosures concerning infrastructure delays. CoreWeave, for its part, hasn’t responded to requests for comment in those statements.

Monday’s session saw the stock finish 7.6% higher, following a jagged run-up that traders chalked up to headline-driven volatility and a lack of strong views on valuation before earnings land.

CoreWeave will release its fourth-quarter and full-year 2025 earnings on Feb. 26, followed by a conference call at 5 p.m. Eastern. The focus for investors: updates around booked capacity, delivery schedules, and capital spending.

CoreWeave has relied on its Nvidia ties to push growth. Back in January, Nvidia CEO Jensen Huang described AI as “entering its next frontier and driving the largest infrastructure buildout in human history,” as the company committed $2 billion to CoreWeave. Investing.com

Even so, the trade is volatile. CoreWeave continues to face skepticism over the timing of its data-center expansions and the risk that escalating costs might outpace revenue. Those worries reemerged late last year after the company reported operational setbacks.

Nvidia barely budged on Tuesday, while the Nasdaq-focused QQQ ETF crept up. That left CoreWeave’s drop looking more like a company story than a market-wide move.

Next moves are clear enough, though shares remain choppy. Traders are waiting on any word from the company regarding litigation notices and fresh insider-sale filings. But the real driver is still the Feb. 26 earnings report and call.

Stock Market Today

  • SpaceX IPO Filing Reveals Financials, Musk Could Become First Trillionaire
    May 20, 2026, 7:08 PM EDT. SpaceX filed for an initial public offering (IPO), disclosing its finances and board members for the first time. The company reported $18.7 billion in revenue for 2025, up 33% year-on-year, but posted a net loss of $4.9 billion, reversing a $791 million profit in 2024. First-quarter 2026 losses reached $4.3 billion on $4.7 billion revenue. The IPO, trading as SPCX, may become the largest ever, potentially boosting Elon Musk's wealth to trillionaire status. SpaceX aims to fund its ambitious plans including Starlink satellite network expansion, AI infrastructure, and establishing extraterrestrial colonies.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Eli Lilly stock price dips as $2.4 billion Orna deal and China pact grab attention
Previous Story

Eli Lilly stock price dips as $2.4 billion Orna deal and China pact grab attention

Abpro Holdings stock slides in premarket after Goldman stake filing sparks wild ABP swings
Next Story

Abpro Holdings stock slides in premarket after Goldman stake filing sparks wild ABP swings

Go toTop